Lv6
2435 积分 2022-04-04 加入
[Expert consensus on the monitoring and risk assessment of QT interval prolongation]
2天前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
12天前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
12天前
已完结
[Expert consensus on amivantamab clinical application and adverse reaction management (2025 edition)]
15天前
已完结
Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy
20天前
已完结
Associations of demographics, aggravating factors, comorbidities, and treatments with atopic dermatitis severity in China: A national cross-sectional study
20天前
已完结
Natural history of untreated colonic polyps
22天前
已完结
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
26天前
已完结
Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy
1个月前
已完结
Atopic dermatitis
1个月前
已完结
皖公网安备34019202002308
